Serge Eholié

机构：Université Félix Houphouët-Boigny

发表论文 92 篇 · 总被引 3622 次 · h-index 25

代表论文

• Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial (2021 · The Lancet Infectious Diseases · 被引 31)
• Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa (2021 · BMC Immunology · 被引 16)
• Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory (2023 · EBioMedicine · 被引 10)
• Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial (2024 · The Lancet HIV · 被引 8)
• High Performance of Systematic Combined Urine Liboarabinomannan Test and Sputum Xpert MTB/RIF for Tuberculosis Screening in Severely Immunosuppressed Ambulatory Adults With Human Immunodeficiency Virus (2023 · Clinical Infectious Diseases · 被引 8)
• Plasma sVCAM‐1, antiretroviral therapy and mortality in HIV‐1‐infected West African adults (2022 · HIV Medicine · 被引 6)